1. Home
  2. FMN vs ONCY Comparison

FMN vs ONCY Comparison

Compare FMN & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Federated Hermes Premier Municipal Income Fund

FMN

Federated Hermes Premier Municipal Income Fund

SELL

Current Price

$10.08

Market Cap

85.2M

Sector

Finance

ML Signal

SELL

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

SELL

Current Price

$0.35

Market Cap

80.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FMN
ONCY
Founded
2002
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
85.2M
80.5M
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
FMN
ONCY
Price
$10.08
$0.35
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
★ $4.43
AVG Volume (30 Days)
40.1K
★ 1.1M
Earning Date
01-01-0001
11-13-2026
Dividend Yield
★ 3.86%
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.77
$0.33
52 Week High
$11.76
$1.30

Technical Indicators

Market Signals
Indicator
FMN
ONCY
Relative Strength Index (RSI) 34.94 36.43
Support Level $9.77 N/A
Resistance Level $11.32 $0.46
Average True Range (ATR) 0.11 0.05
MACD -0.06 0.01
Stochastic Oscillator 2.31 11.91

Price Performance

Historical Comparison
FMN
ONCY

About FMN Federated Hermes Premier Municipal Income Fund

Federated Hermes Premier Municipal Income Fund is a United States-based diversified, closed-end management investment company. The investment objective of the fund is to provide current income exempt from federal income tax, including the federal alternative minimum tax by investing in long-term, tax exempt municipal bonds diversified among states, sectors and issuers. Its portfolio of investments comprises different sectors such as hospitals, toll road, senior care, airport, tobacco, and other sectors.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: